• Editor-in-Chief

    Jose Carlos Fernandez-Checa, PhD

    Professor of the Spanish National Research Council at the Institute of Biomedical Research of Barcelona (IIBB-CSIC); Institute of Biomedical Research August Pi i Sunyer (IDIBAPS); CIBEREHD; Barcelona, Spain.
    Email: josecarlos.fernandezcheca@iibb.csic.es
    Associate Editors

    Agustín Albillos, MD, PhD

    Interests: cirrhosis, portal hypertension, gut-liver axis, acute-on-chronic liver failure
    Professor of Medicine, University of Alcalá. Head, Department of Gastroenterology and Hepatology, Hospital Ramón y Cajal. Madrid, Spain

    Matias A. Avila, PhD

    Interests: cellular and molecular mechanisms of the hepatic response, genetic mechanisms of chronic liver disease, biomarkers
    Professor of Biochemistry and Molecular Biology and director of the Hepatology Program of the Center for Applied Medical Research at the University of Navarra, Pamplona, Spain.

    Ina Bergheim, PhD

    Interests: nutrition, intestinal barrier, alcohol-related liver disease, NAFLD, bacterial endotoxin, aging
    Professor, Department of Nutritional Sciences, University of Vienna, Vienna, Austria

    Wen-Xing Ding, PhD

    Interests: autophagy, mitochondria, alcohol associated liver disease, alcohol-associated pancreatitis, drug-induced liver injury (DILI), lipid metabolism
    Professor, University of Kansas Medical Center, Kansas City, KS, USA

    Kenichi Ikejima, MD, PhD

    Interests: pathophysiology of alcohol-related liver disease and NAFLD/NASH, liver immunology, sinusoidal cell biology and hepatic fibrogenesis
    Professor of Medicine, Department of Gastroenterology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

    Eun Hee Koh, MD, PhD

    Interests: Non-alcholic steatohepatitis
    Professor, Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Republic of Korea

    Maria Carlota Londoño, MD, PhD

    Interests: liver diseases, autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, hepatitis C, liver transplantation
    Hepatologist, Hospital Clinic Barcelona, Associate professor, University of Barcelona, Barcelona, Spain.

    Derek A. Mann, PhD

    Interests: liver fibrosis, liver cancer, replicative senescence, tissue ageing, inflammation, immunobiology
    Professor of Hepatology, Biosciences Institute, University of Newcastle, Newcastle, United Kingdom

    Jose J. G. Marin, PhD

    Interests: bile acids, cholestasis, liver and gastrointestinal cancer, chemoresistance and chemosensitization, drug targeting, gene therapy
    Professor, Head of Dept. Physiology & Pharmacology, University of Salamanca; Experimental Hepatology and Drug Targeting (HEVEPHARM); Carlos III National Institute of Health, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd); Salamanca Institute for Biomedical Research (IBSAL); Salamanca, Spain.

    Fabio Marra, MD, PhD

    Interests: cellular and molecular mechanisms of hepatic inflammation and fibrogenesis, pathophysiology of nonalcoholic steatohepatitis, hepatobiliary neoplasia, non-invasive evaluation of liver fibrosis
    Professor of Medicine and Director of the Internal Medicine and Liver Unit, University of Florence, Italy

    Maria L. Martinez-Chantar, PhD

    Interests: liver care, non-invasive assays for NASH diagnosis, metabolomics
    Professor, School of Medicine, University of Deusto; CIC bioGUNE; CIBERehd – Spanish Carlos III Health Institute; Derio, Spain

    Han Moshage, PhD

    Interests: chronic liver diseases, apoptosis, necrosis, lipotoxicity, fatty liver diseases, oxidative stress, signal transduction, fibrosis, inflammation, hepatocytes, Kupffer cells, stellate cells
    Professor of Experimental Hepatology and Gastroenterology, Dept. of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

    Natalia Nieto, Pharm.D, PhD

    Interests: alcoholic liver disease, fibrosis, NASH
    Professor, Department of Pathology, Department of Medicine (Gastroenterology and Hepatology), University of Illinois at Chicago, Chicago, USA

    Oren Tirosh, PhD

    Interests: oxidative stress and metabolic diseases, NAFLD/NASH, hepatocytes cell death, redox signaling, cholesterol and bile acids biology.
    Professor of Nutritional Sciences. Head, Institute of Biochemistry, Food Science and Nutrition. The Robert H. Smith Faculty of Agriculture, Food and Environment. The Hebrew University of Jerusalem. Rehovot, Israel.

    William Ka Kei Wu, PhD

    Interests: gastric cancer, colorectal cancer, liver cancer, probiotics, H. pylori, NAFLD, genomics, autophagy
    Associate Professor (Non-clinical), State Key Laboratory of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
    Editorial Board Members

    María Arechederra, PhD

    Interests: liver cancer, HCC/CCA, molecular mechanisms of liver carcinogenesis, genetics and epigenetics, DNA methylation, liquid biopsy biomarkers
    Researcher, Hepatology Program, Center for Applied Medical Research (Cima), University of Navarra, Pamplona, Spain.

    Carmen Berasain, PhD

    Interests: cellular and molecular mechanisms of hepatocarcinogenesis, gene expression regulation, liquid biopsy strategies
    Professor of Biochemistry and Molecular Biology and sub-director of the Hepatology Program of the CIMA at the University of Navarra, Pamplona, Spain.

    Francisco Javier Cubero, PhD

    Interests: liver, ER, JNK, ASH, DILI, cholestasis, HCC/CCA
    Professor of Medicine (Immunology), Department of Immunology, Ophthalmology & ENT, Complutense University School of Medicine, Madrid, Spain.

    Robert Eferl, PhD

    Interests: colorectal cancer, colorectal cancer metastasis, intestinal barrier function, cytokine signaling
    Professor, Center for Cancer Research, Medical University of Vienna, Vienna, Austria.

    Maite G. Fernandez-Barrena, PhD

    Interests: chronic liver diseases, MAFLD, NASH, fibrosis, hepatocarcinogenesis, epigenetics
    Ramon y Cajal Investigator; Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain.

    Carmen Garcia-Ruiz, PhD

    Interests: mitochondria, lipid metabolism, oxidative stress, cell death, gender differences in NASH driven HCC
    Professor, Spanish National Research Council, Department of Cell Death and Proliferation (IIBB-CSIC); August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Research Center Network of Hepatic and Digestive Diseases (CIBERehd-ISCIII); Barcelona, Spain.

    Luis E. Gomez-Quiroz, PhD

    Interests: biology and pathobiology of liver and pancreas diseases, liver cancers, signal transduction and redox biology
    Professor and principal investigator at Universidad Autonoma Metropolitana, Mexico City.

    Claus Hellerbrand, MD

    Interests: molecular mechanisms of chronic liver disease including liver cancer and hepatic metastasis
    Professor for Biochemistry and Molecular Pathobiology, Institute of Biochemistry, Friedrich-Alexander University Erlangen-Nürnberg, Germany

    Anna Moles, PhD

    Interests: liver fibrosis, extracellular matrix remodeling, proteolytic networks and biological signaling pathways during chronic liver disease
    Research Scientist of the Spanish National Research Council at the Institute of Biomedical Research of Barcelona (IIBB-CSIC); Institute of Biomedical Research August Pi i Sunyer (IDIBAPS); CIBEREHD; Barcelona, Spain.

    Maria J. Monte, PhD

    Interests: bile acids, cholestasis, liver metabolism
    Professor of Physiology, Department of Physiology & Pharmacology, University of Salamanca; Experimental Hepatology and Drug Targeting (HEVEPHARM); Carlos III National Institute of Health, Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd); Salamanca Institute for Biomedical Research (IBSAL); Salamanca, Spain.